Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel.
| Autor: | Haile PA, Casillas LN, Bury MJ, Mehlmann JF, Singhaus R Jr, Charnley AK, Hughes TV, DeMartino MP, Wang GZ, Romano JJ, Dong X, Plotnikov NV, Lakdawala AS, Duraiswami C, Convery MA, Votta BJ, Lipshutz DB, Desai BM, Swift B, Capriotti CA, Berger SB, Mahajan MK, Reilly MA, Rivera EJ, Sun HH, Nagilla R, LePage C, Ouellette MT, Totoritis RD, Donovan BT, Brown BS, Chaudhary KW, Gough PJ, Bertin J, Marquis RW |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 Jun 02; Vol. 11 (6), pp. 1353. Date of Electronic Publication: 2020 Jun 02 (Print Publication: 2020). |
| DOI: | 10.1021/acsmedchemlett.0c00260 |
| Abstrakt: | [This corrects the article DOI: 10.1021/acsmedchemlett.8b00344.]. (Copyright © 2020 American Chemical Society.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|